Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center — New York, New York

Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory, Multiple Myeloma.

Sponsors: Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center?

Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center conducted?

Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center has 1 clinical trials on record. Their work covers Relapsed/Refractory, Multiple Myeloma.

Is Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center accredited by Crixeo Health?

Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.